fbpx
QQQ
+ 2.69
322.73
+ 0.83%
DIA
-0.16
310.10
-0.05%
SPY
+ 1.72
381.10
+ 0.45%
TLT
+ 1.79
150.09
+ 1.18%
GLD
+ 0.14
173.75
+ 0.08%

Why Is It Moving? Looking At Document Security Systems, Inc. Common Stock's Price Action Today

December 23, 2020 11:07 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Why Is It Moving? Looking At Document Security Systems, Inc. Common Stock's Price Action Today

The Price And Volume Action In Document Security Systems, Inc. Common Stock's Stock Today

Document Security Systems, Inc. Common Stock’s (AMEX:DSS) stock has been rising Wednesday, up 4.5% to a price of $6.67. Wednesday the stock has been traded at a volume of 164.54 thousand, about 68.42% of its recent 30-day volume average of 240.50 thousand.

Why It’s Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Document Security Systems shares are trading higher after the company's Impact BioMedical subsidiary entered an exclusive distribution agreement with BioMed Technology Asia Pacific Holdings Limited.

Further Analysis of Recent Price Action

The stock’s 50-day moving average was $5.06 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $10.55 and fallen to a low of $0.12.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.

Posted-In:

Movers Trading Ideas

Related Articles

68 Biggest Movers From Yesterday

Gainers Obalon Therapeutics Inc (NASDAQ: OBLN) shares jumped 414.3% to close at $8.28 on Wednesday after the company announced a merger agreement with ReShape Lifesciences. read more

45 Stocks Moving In Wednesday's Mid-Day Session

Gainers Obalon Therapeutics Inc (NASDAQ: OBLN) shares jumped 175% to $4.4250 after the company announced a merger agreement with ReShape Lifesciences. read more

40 Stocks Moving in Wednesday's Pre-Market Session

Gainers Caladrius Biosciences, Inc. (NASDAQ: CLBS) rose 132.4% to $3.79 in pre-market trading. Caladrius Biosciences said it treated first patient in Phase 2b FREEDOM trial of CLBS16 for the treatment of coronary microvascular dysfunction. read more

Document Security System's Impact BioMedical Receives Notice Of Allowance For 3F Biofragrance Patent

DSS's Impact BioMedical Receives Notice of Allowance for 3F Biofragrance Patent ROCHESTER, N.Y., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. ("DSS" or the "Company") read more